Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.67 - $39.61 $1.17 Million - $1.67 Million
-42,106 Reduced 67.46%
20,307 $777,000
Q4 2023

Feb 14, 2024

BUY
$30.6 - $43.78 $1.91 Million - $2.73 Million
62,413 New
62,413 $1.95 Million
Q3 2020

Nov 16, 2020

SELL
$45.65 - $61.81 $1.09 Million - $1.47 Million
-23,796 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$29.15 - $61.54 $693,653 - $1.46 Million
23,796 New
23,796 $1.46 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.4B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.